Relationship between C9orf72 repeat size and clinical phenotype

Curr Opin Genet Dev. 2017 Jun:44:117-124. doi: 10.1016/j.gde.2017.02.008. Epub 2017 Mar 17.

Abstract

Patient carriers of a C9orf72 repeat expansion exhibit remarkable heterogeneous clinical and pathological characteristics suggesting the presence of modifying factors. In accordance with other repeat expansion diseases, repeat length is the prime candidate as a genetic modifier. Observations of earlier onset ages in younger generations of large families suggested a mechanism of disease anticipation. Yet, studies of repeat size and onset age have led to conflicting results. Also, the correlation between repeat size and diagnosis is poorly understood. We review what has been published regarding C9orf72 repeat size as modifier for phenotypic characteristics. Conclusive evidence is lacking, partly due to the difficulties in accurately defining the exact repeat size and the presence of repeat variability due to somatic mosaicism.

Publication types

  • Review

MeSH terms

  • Age of Onset
  • Amyotrophic Lateral Sclerosis / genetics*
  • Amyotrophic Lateral Sclerosis / pathology
  • C9orf72 Protein / genetics*
  • DNA Repeat Expansion / genetics*
  • Frontotemporal Dementia / genetics*
  • Frontotemporal Dementia / pathology
  • Humans
  • Mosaicism
  • Nerve Degeneration / genetics*
  • Nerve Degeneration / pathology
  • Phenotype
  • Repetitive Sequences, Amino Acid / genetics

Substances

  • C9orf72 Protein
  • C9orf72 protein, human